Covid Vaccines Associated With ALL Cases of Heart Inflammation in Children in a Large UK Health Dataset
Covid Vaccines Associated With ALL Cases of Heart Inflammation in Children in a Large UK Health Dataset
by Sasha Latypova, Due Diligence and Art
October 1, 2024
This paper has been published in peer review.
Conclusions of this observational study in ~800K children and adolescents in the UK: covid vaccines had no efficacy and were associated with ALL cases of myocarditis and pericarditis! Anyone injecting kids with this garbage is simply poisoning them for no reason at all. You can read for yourself:
OpenSAFELY: Effectiveness of COVID-19 vaccination in children and adolescents
Colm D Andrews[1] , Edward P K Parker[2] , Elsie Horne[4] , Venexia Walker[4] , Tom Palmer[4] , Andrea L Schaffer[1] , Amelia CA Green[1] , Helen J Curtis[1] , Alex J Walker[1] , Lucy Bridges[1] , Christopher Wood[1] , Victoria Speed[1] , Christopher Bates[3] , Jonathan Cockburn[3] , John Parry[3] , Amir Mehrkar[1] , Brian MacKenna[1], Sebastian CJ Bacon[1] , Ben Goldacre[1] , Miguel A Hernan[5] , Jonathan AC Sterne[4] , The OpenSAFELY Collaborative, and William J Hulme[1] .
[1]Bennett Institute for Applied Data Science, Nuffield Department of Primary Care Health Sciences, University of Oxford, OX2 6GG, UK
[2] London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UK
[3] TPP, TPP House, 129 Low Lane, Horsforth, Leeds, LS18 5PX, UK
[4] Population Health Sciences, University of Bristol, Oakfield House, Oakfield Grove, Bristol, BS8 2BN, UK
[5] Departments of Epidemiology and Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA 02115
Abstract:
Background Children and adolescents in England were offered BNT162b2 as part of the national COVID-19 vaccine roll out from September 2021. We assessed the safety and effectiveness of first and second dose BNT162b2 COVID-19 vaccination in children and adolescents in England.
Methods:
With the approval of NHS England, we conducted an observational study in the OpenSAFELY-TPP database, including a) adolescents aged 12-15 years, and b) children aged 5-11 years and comparing individuals receiving i) first vaccination with unvaccinated controls and ii) second vaccination to single-vaccinated controls. We matched vaccinated individuals with controls on age, sex, region, and other important characteristics. Outcomes were positive SARS-CoV-2 test (adolescents only); COVID-19 A&E attendance; COVID-19 hospitalisation; COVID-19 critical care admission; COVID-19 death, with non-COVID-19 death and fractures as negative control outcomes and A&E attendance, unplanned hospitalisation, pericarditis, and myocarditis as safety outcomes.
Results:
Amongst 820,926 previously unvaccinated adolescents, the incidence rate ratio (IRR) for positive SARS-CoV-2 test comparing vaccination with no vaccination was 0.74 (95% CI 0.72-0.75), although the 20-week risks were similar. The IRRs were 0.60 (0.37-0.97) for COVID-19 A&E attendance, 0.58 (0.38-0.89) for COVID-19 hospitalisation, 0.99 (0.93-1.06) for fractures, 0.89 (0.87- 0.91) for A&E attendances and 0.88 (0.81-0.95) for unplanned hospitalisation. Amongst 441,858 adolescents who had received first vaccination IRRs comparing second dose with first dose only were 0.67 (0.65-0.69) for positive SARS-CoV-2 test, 1.00 (0.20-4.96) for COVID-19 A&E attendance, 0.60 (0.26-1.37) for COVID-19 hospitalisation, 0.94 (0.84-1.05) for fractures, 0.93 (0.89-0.98) for A&E attendance and 0.99 (0.86-1.13) for unplanned hospitalisation. Amongst 283,422 previously unvaccinated children and 132,462 children who had received a first vaccine dose, COVID-19-related outcomes were too rare to allow IRRs to be estimated precisely. A&E attendance and unplanned hospitalisation were slightly higher after first vaccination (IRRs versus no vaccination 1.05 (1.01- 1.10) and 1.10 (0.95-1.26) respectively) but slightly lower after second vaccination (IRRs versus first dose 0.95 (0.86-1.05) and 0.78 (0.56-1.08) respectively). There were no COVID-19-related deaths in any group. Fewer than seven (exact number redacted) COVID-19-related critical care admissions occurred in the adolescent first dose vs unvaccinated cohort.
Among both adolescents and children, myocarditis and pericarditis were documented only in the vaccinated groups, with rates of 27 and 10 cases/million after first and second doses respectively. Conclusion BNT162b2 vaccination in adolescents reduced COVID-19 A&E attendance and hospitalisation, although these outcomes were rare. Protection against positive SARS-CoV-2 tests was transient.
“Myocarditis and pericarditis ONLY in vaccinated”
“Protection against a positive TEST – transient”
you read this correctly!
Cover image credit: fujikama